Spots Global Cancer Trial Database for ISP-TACE Versus TACE for HCC With PVTT

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: ISP-TACE Versus TACE for HCC With PVTT

Official Title: Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: Survival Benefit of Transarterial Chemoembolization in Combination With Irradiation Stent Placement

Study ID: NCT03108248

Conditions

HCC

Portal Vein Tumor Thrombosis

Interventions

ethiodized oil; doxorubicin;Gelfoam;

stent; idoine-125

Study Description

Brief Summary: For patients with advanced hepatocellular carcinoma (HCC) and portal vein tumor thrombosis (PVTT), the survival benefit of transarterial chemoembolization (TACE) remains modest. This study aimed to investigate whether TACE in combination with irradiation stent placement (ISP) could prolong the survival in patients with HCC and PVTT.

Detailed Description: